Neutralising Antibody Detection Kits for SARS-CoV-2 Variants
Product Name | PID | Application/Activity |
SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.1.7 Variant, Alpha) | AG-48B-0003 | To measure the presence of neutralising/blocking antibodies in human serum/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (B.1.1.7 Variant, Alpha) protein to its human receptor ACE2. |
SARS-CoV-2 Neutralizing Antibodies Detection Kit (P.1 Variant, Gamma) | AG-48B-0004 | To measure the presence of neutralising/blocking antibodies in human serum/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (P.1 Variant, Gamma) protein to its human receptor ACE2. |
SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.351 Variant, Beta) | AG-48B-0005 | To measure the presence of neutralising/blocking antibodies in human serum/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (B.1.351 Variant, Beta) protein to its human receptor ACE2. |
SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.617.1 Variant, Kappa) | AG-48B-0006 | To measure the presence of neutralising/blocking antibodies in human serum/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (B.1.617.1 Variant, Kappa) protein to its human receptor ACE2. |
NEW SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.617.2 Variant, Delta) | AG-48B-0007 | To measure the presence of neutralising/blocking antibodies in human serum/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (B.1.617.2 Variant, Delta) protein to its human receptor ACE2. |
The STANDARD for Initial SARS-CoV-2 Strain SARS-CoV-2 Neutralizing Antibodies Detection Kit | AG-48B-0002 | To measure the presence of neutralising/blocking antibodies in human serum/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (initial strain) protein to its human receptor ACE2. |
Originally posted on adipogen.com/covid-19
Caltag Medsystems is the distributor of Adipogen products in the UK and Ireland. If you have any questions about these products, please contact us.
Neutralising Antibody Detection Kits for SARS-CoV-2 Variants